人参多糖辅助治疗糖尿病合并肺结核患者的近期临床观察

摘要/Abstract

摘要： 目的探讨人参多糖辅助治疗2型糖尿病合并肺结核的近期临床效果。方法选择2011年1月至2011 年12月汕头市结核病防治所的门诊2 型糖尿病合并肺结核患者，全部患者结核病的诊断均符合《临床诊疗指南结核病分册》中所制定的标准，所有患者2型糖尿病的诊断符合中华医学会糖尿病学分会 2009年颁布的《中国糖尿病防治指南》中所制定的标准。将120 例2 型糖尿病合并肺结核患者按门诊登记的单双号数随机分为实验组62例和对照组58例。实验组在行常规抗结核和降糖治疗的同时加用人参多糖（隔日一次肌内注射，每次12mg），共计 180d；对照组仅行常规抗结核、降糖治疗，共计 180d。观察两组的短期治疗效果和T细胞亚群变化,并加以比较。采用SPSS 13.0 统计学软件进行分析，计量资料采用t检验,率比较采用χ²检验，P<0.05为差异有统计学意义。结果人参多糖辅助治疗180d后，实验组患者痰菌阴转率为95.2％（59/62），明显高于对照组患者的79.3%（46/58）（χ²=6.88，P<0.01）；实验组患者治疗的有效率达96.8%（60/62）,明显高于对照组患者的75.9%（44/58）(χ²=11.34, P<0.01）。实验组患者治疗后外周血液检测，CD3⁺为(50.00±10.42)%，治疗前为(34.89±7.26)%，对照组患者治疗后检测为(37.46±8.96)%；实验组治疗后分别与后二者比较(t值分别为9.36、7.04,P值均＜0.01）。实验组患者治疗后外周血液检测，CD4⁺为(34.88±9.96)%，治疗前为(25.89±8.68)%，对照组患者治疗后为(25.64±9.68)%；实验组治疗后分别与后二者比较，t值分别为5.38、5.11, P值均＜0.01。实验组患者治疗后外周血液检测，CD4⁺/CD8⁺值为1.58±0.78，治疗前为1.15±0.45，对照组患者治疗后检测值为1.20±0.62；实验组治疗后分别与后二者比较，t值分别为3.76、2.94, P值均＜0.01。实验组患者治疗后外周血液检测，CD8^＋为(18.50±7.22)%，治疗前为(24.76±9.85)%，对照组患者治疗后为(23.86±8.92)%；实验组治疗后分别与后二者比较，t值分别为4.03、3.63, P值均＜0.01。与治疗前及对照组治疗后比较差异均有统计学意义。结论采用人参多糖辅助治疗 2 型糖尿病合并肺结核患者的痰菌阴转、治疗有效率、细胞免疫功能改善均有明显的促进作用。

关键词: 结核, 肺, 糖尿病, 2型, 人参属, 多糖类

Abstract: Objective To investigate the curative effect of ginseng polysaccharide on adjuvant therapy of type 2 diabetes combined with pulmonary tuberculosis(PTB). Methods One hundred and twenty outpatients with diabetes combined with PTB notified in Shantou Institute of Tuberculosis Control and Prevention from January to December,2011 were the study targets. The diagnosis of TB was accord with the standard of Clinical Practice Guidelines for Tuberculosis, and the diagnosis of type 2 diabetes was accord with the standard of China Guideline for Diabetes issued in 2009 by Chinese Diabetes Society. One hundred and twenty patients were randomly divided into experimental group(62 cases)and control group(58 cases)based on oddeven notified number. Routine antiTB and glucoselowering treatment were applied in control group(180days),while ginseng polysaccharide was given(12mg intramuscular injection every other day for 180days)to experimental group besides the routine treatment. The short term effect and the change of T cell subset of the two groups were compared. SPSS 13.0 software was used for data analysis,ttest was used for quantitative data andχ² test was applied for rate comparison. P<0.05 was set as the standard of statistical significance. Results The sputum conversion rate of experimental group was 95.2%(59/62), which was significantly higher than that of the control group(79.3%,46/58)(χ²=6.88, P<0.01). The effective rate of experimental group(96.8%,60/62)was also significantly higher than control group(75.9%, 44/58)(χ²=11.34, P<0.01). From peripheral blood testing,the proportions of CD3⁺ T cells in patients in experimental group was(50.0±10.42)% after treatment and(34.89±7.26)%before treatment,and the proportion in patients in control group was(37.46±8.96)%before treatment, tvalues were 9.36 and 7.04 respectively compared with the latter two,and both P value were less than 0.01. The proportions of CD4⁺T cell in experimental group were(34.88±9.96)% after treatment and(25.89±8.68)% before treatment,while that in control group after treatment was(25.64±9.68)% after treatment, tvalues were 5.38 and 5.11 compared with the latter two with P<0.01. The ratios of CD4/CD8 were 1.58±0.78,1.15±0.45 and 1.20±0.62 respectively,and the tvalues were 3.76 and 2.94 compared with the latter two with P<0.01. The proportions of CD8⁺T cell were(18.50±7.22)%,(24.76±9.85)%and(23.86±8.92)%respectively,and the tvalues were 4.03 and 3.63 compared with the latter two with P<0.01. Conclusion The sputum conversion rate,effective rate and cellular immune function were clearly improved by ginseng polysaccharide on diabetes combined with PTB.

Key words: Tuberculosis, pulmonary, Diabetes mellitus, type 2, Panax, Polysaccharides

蔡清河林健雄黄松武陈怀一. 人参多糖辅助治疗糖尿病合并肺结核患者的近期临床观察[J]. 中国防痨杂志, 2013, 35(7): 533-537.

CAI Qing-he，LIN Jian-xiong，HUANG Song-wu,CHEN Huai-yi. Curative effect of ginseng polysaccharide on adjuvant therapy of diabetes combined with pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2013, 35(7): 533-537.

参考文献

［1］承解静，姚生华，费瑞银，等．糖尿病合并感染者免疫功能改变的临床观察.中华内分泌代谢杂志，2000,16（3）：191-192.
［2］中华医学会.临床诊疗指南结核病分册.北京：人民卫生出版社，2004.
［3］中华人民共和国卫生部疾病预防控制局，中华人民共和国卫生部医政司，中国疾病预防控制中心.中国结核病防治规划实施工作指南（2008年版）．北京：中国协和医科大学出版社，2009.
［4］中国防痨协会．结核病诊断细菌学检验规程．中国防痨杂志，1996，18（1）：28-31．
［5］中华医学会结核病学分会．肺结核化学疗法．中华结核和呼吸杂志，1982,5（6）：381-385．
［6］Grange JM,Zumla A. The global emergency of tuberculosis:what is the cause ? J R Soc Promot Health,2002,122(2):78-81.
［7］Unwin N,Alberti KG. Chronic non-communicable diseases. Ann Trop Med Parasitol, 2006, 100(5/6):455-464.
［8］Jetan CA,Jamaiah I,Rohela M,et al. Tuberculosis:an eight year(2000—2007)retrospective study at the University of Malaya Medical Centre(UMMC),Kuala Lumpur,Malaysia. Southeast Asian J Trop Med Public Health,2010,41(2):378-385.
［9］Dhar N,Rao V,Tyagi AK．Skewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG system． Immunol Lett,2003,88(3)：175-184．
［10］李艳，谭守勇，邝浩斌，等．母牛分枝杆菌菌苗辅助治疗对糖尿病并肺结核患者细胞免疫功能低下的疗效．实用医学杂志,2012, 28（12）：1994-1996.
［11］马琴琴，白大鹏，孔伟利，等．胸腺肽α1辅助治疗肺结核合并糖尿病的病例对照研究．临床荟萃，2012，27（1）：19-22.
［12］周晓映，于红艳，王惠青，等．2 型糖尿病合并肺结核患者T淋巴细胞亚群和NK 细胞的变化及其临床意义．疑难病杂志，2008，7（11）：666-668.
［13］Chen HS，Tsai YF,Lin S，et al. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum(Reishi)polysaccharides. Bioorg Med Chem，2004,12(21):5595-5601.
［14］张朝晖，曾超，李灵丰，等．人参多糖改善脓毒症患者T细胞亚群免疫功能的临床研究．江苏中医药，2012，44（6）：32-33．
［15］陈岩菊，杜伟彬，李树臣．人参多糖在肿瘤放射治疗中升白细胞观察．中医药学报，2004,32（2）：55-56.
［16］赵俊，吴宏，王亚平.人参多糖的化学与药理学研究进展．国外医学中医中药分册，2004,26（2）：79-81.
［17］张彬，林瑞超，冯芳．人参多糖的研究概况．中国药事，2004，18（9）：566-569.